Mindfulness therapy shows promise for HIV patients who drink too much

NCT ID NCT03974061

Completed Symptom relief Sponsor: Syracuse University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a short form of Acceptance and Commitment Therapy (ACT) in 49 people living with HIV who were hazardous drinkers. The therapy uses mindfulness and values-based action to reduce drinking and improve medication adherence. Researchers measured drinking days, alcohol levels, and HIV medication adherence over six months to see if the approach was feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Brief Acceptance and Commitment Therapy (ACT)
What this could lead to: If it works, this could offer a practical, short-term therapy to help people with HIV drink less and stick to their HIV medication.
What could go wrong: This was a very small pilot study with only 49 participants, so results may not apply widely. The therapy may not lead to lasting changes in drinking or HIV outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TREATMENT

Contacts and locations

Locations

Syracuse University

Syracuse, New York, 13244, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.